FDA Inspection 1302680 — Dr. Ruben Polo Lopez, MD
The FDA completed an inspection of Dr. Ruben Polo Lopez, MD on Jan 23, 2026 in Madrid. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Madrid (Spain)
Additional details
Clinical Investigator (CI)